ArticleBioengineered2022

tRF-19-W4PU732S promotes breast cancer cell malignant activity by targeting inhibition of RPL27A (ribosomal protein-L27A).

Zhengxiang Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.